Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

2.3 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -33.97-63.344-53.088-16.703-26.587
Depreciation & Amortization 0.8220.5480.4970.5890.564
Deferred Income Tax -21.24701.07100
Stock Based Compensation 19.00815.78222.59500
Change In Working Capital -2.140.509-3.4291.044-0.163
Accounts Receivables 00000
Inventory 00000
Accounts Payables -0.5950.1630.5430.933-0.271
Other Working Capital -1.5450.346-3.9720.1110.108
Other Non Cash Items -13.709-0.010.1090.11-0.081
Operating Cash Flow -51.236-46.515-32.245-14.96-26.267
Investing Activities:
Investments In Property Plant And Equipment -1.229-1.619-0.506-1.2-1.581
Acquisitions Net -2.316-0.851000.049
Purchases Of Investments -73.261-73.817000
Sales Maturities Of Investments 104.353000
Other Investing Activites 2.3160.851000
Investing Cash Flow 29.86-72.436-0.506-1.2-1.532
Financing Activities:
Debt Repayment 0-29.314-4.568-1.41-0.852
Common Stock Issued 0.3950.31773.64871.2720
Common Stock Repurchased -0-0.001000
Dividends Paid 00000
Other Financing Activities 0-0.6268.0662.820.852
Financing Cash Flow 029.00577.14672.6820.852
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -21.143-89.94644.39556.522-26.947
Cash At End Of Period 6.36427.507117.45373.05816.536